Items where Author is "Hartmann, Rolf W."

February 2020

Patt, Melanie and Beck, Katharina R. and Di Marco, Tobias and Jäger, Marie-Christin and González-Ruiz, Victor and Boccard, Julien and Rudaz, Serge and Hartmann, Rolf W. and Salah, Mohamed and van Koppen, Chris J. and Grill, Matthias and Odermatt, Alex. (2020) Profiling of anabolic androgenic steroids and selective androgen receptor modulators for interference with adrenal steroidogenesis. Biochemical pharmacology, 172. p. 113781.

2020

Mayr, Fabian and Möller, Gabriele and Garscha, Ulrike and Fischer, Jana and Rodríguez Castaño, Patricia and Inderbinen, Silvia G. and Temml, Veronika and Waltenberger, Birgit and Schwaiger, Stefan and Hartmann, Rolf W. and Gege, Christian and Martens, Stefan and Odermatt, Alex and Pandey, Amit V. and Werz, Oliver and Adamski, Jerzy and Stuppner, Hermann and Schuster, Daniela. (2020) Finding New Molecular Targets of Familiar Natural Products Using In Silico Target Prediction. International Journal of Molecular Sciences, 21 (19). p. 7102.

2019

Akram, Muhammad and Patt, Melanie and Kaserer, Teresa and Temml, Veronika and Waratchareeyakul, Watcharee and Kratschmar, Denise V. and Haupenthal, Joerg and Hartmann, Rolf W. and Odermatt, Alex and Schuster, Daniela. (2019) Identification of the fungicide epoxiconazole by virtual screening and biological assessment as inhibitor of human 11β-hydroxylase and aldosterone synthase. Journal of Steroid Biochemistry and Molecular Biology, 192. p. 105358.

2018

Emmerich, Juliette and van Koppen, Chris J. and Burkhart, Jens L. and Engeli, Roger T. and Hu, Qingzhong and Odermatt, Alex and Hartmann, Rolf W.. (2018) Accelerated skin wound healing by selective 11β²-Hydroxylase (CYP11B1) inhibitors. European journal of medicinal chemistry, 143. pp. 591-597.

2013

Marchais-Oberwinkler, Sandrine and Xu, Kuiying and Wetzel, Marie and Perspicace, Enrico and Negri, Matthias and Meyer, Arne and Odermatt, Alex and Möller, Gabriele and Adamski, Jerzy and Hartmann, Rolf W.. (2013) Structural Optimization of 2,5-Thiophene Amides as Highly Potent and Selective 17β-Hydroxysteroid Dehydrogenase Type 2 Inhibitors for the Treatment of Osteoporosis. Journal of Medicinal Chemistry, Vol. 56, H. 1. pp. 167-181.